← Evidence map

ArticleOphthalmology and therapy2017

Twice-Daily vs. Once-Daily Dosing with 0.075% Bromfenac in DuraSite: Outcomes from a 14-Day Phase 2 Study.

William Trattler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2017
2018
2019
2020
2021
2022
2023
this papercites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 28819932